303 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Unknown  Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms
Condition: Urinary Bladder, Overactive
Interventions: Drug: solifenacin succinate;   Drug: fesoterodine
22 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Breast Cancer;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Bladder Cancer
Intervention: Drug: IMMU-132
23 Recruiting A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Condition: Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms
Intervention: Drug: MPDL3280A
24 Unknown  Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
Conditions: Urinary Urge;   Urge Incontinence;   Overactive Bladder
Interventions: Drug: solifenacin succinate;   Drug: placebo
25 Unknown  Biomarker Discovery and Application in Bladder Cancer
Condition: Bladder Cancer
Intervention:
26 Unknown  Premarin Versus Toviaz for Treatment of Overactive Bladder
Condition: Overactive Bladder
Intervention: Drug: Toviaz, Premarin Vaginal Cream
27 Unknown  Endoscopic Resection of Bladder Tumors
Condition: Bladder Tumor
Intervention: Other: Endoscopic resection under blue light (Hexvix®)
28 Recruiting Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients
Condition: Bladder Hyperactivity
Intervention: Device: Device:   INTERSTIM II
29 Unknown  PF-03446962 in Relapsed or Refractory Urothelial Cancer
Condition: Transitional Cell Carcinoma of Bladder
Intervention: Drug: PF03446962
30 Recruiting Radiation Therapy After Surgery in Treating Patients With High-Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
31 Unknown  Sacral Neuromodulation in Patients With IC
Condition: Interstitial Cystitis
Intervention: Device: Interstim
32 Recruiting Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment
Condition: Interstitial Cystitis
Interventions: Drug: Botulinum toxin A;   Drug: Normal saline instillation
33 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Adenocarcinoma of the Bladder;   Recurrent Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: sirolimus;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Procedure: therapeutic conventional surgery
34 Not yet recruiting Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort
Conditions: Catheter Site Discomfort;   Complications;   Anesthesia;   Urinary Bladder Neoplasms
Interventions: Drug: Glycopyrrolate;   Drug: Atropine
35 Unknown  The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
Condition: Overactive Bladder Syndrome
Intervention:
36 Recruiting Development of Novel Cystometrics for Overactive Bladder
Condition: Urinary Frequency/Urgency
Intervention:
37 Not yet recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
Condition: Overactive Bladder (OAB)
Interventions: Drug: Mirabegron;   Drug: Placebo
38 Recruiting Study of Overactive Bladder in Women With Prolapse
Conditions: Urinary Bladder, Overactive;   Pelvic Organ Prolapse
Intervention: Other: Pre- and postoperative evaluations
39 Unknown  Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Conditions: Bladder Cancer;   Brain and Central Nervous System Tumors;   Esophageal Cancer;   Intraocular Melanoma;   Kidney Cancer;   Lymphoma;   Melanoma (Skin);   Pancreatic Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
40 Recruiting Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Conditions: Breast Cancer;   Bladder Cancer;   Kidney Cancer;   Colon Cancer;   Prostate Cancer;   Lung Cancer
Intervention: Genetic: PCR/PCR/LDR Strategy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years